BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37482462)

  • 1. [The quality manager in radiation therapy: Evolution of the role, presentation of a French national Survey].
    Brusadin G; Cucchiaro S; Nardin S; Leroy É
    Cancer Radiother; 2023 Sep; 27(6-7):573-576. PubMed ID: 37482462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality/risk management system in radiotherapy: Changes afoot.
    Pourel N; Meyrieux C; Lisbona A
    Cancer Radiother; 2022; 26(1-2):14-19. PubMed ID: 34953695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk analysis in radiation therapy: state of the art].
    Mazeron R; Aguini N; Deutsch É
    Cancer Radiother; 2013; 17(4):308-16, quiz 332. PubMed ID: 23787020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French Health Authority certification visit in a radiotherapy department].
    Ponsard N; Heddadi L; Pradier O
    Cancer Radiother; 2020 Oct; 24(6-7):722-725. PubMed ID: 32792296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality and safety policy implementation for a new radiotherapy device].
    Martin C; Jumeau R; Blais E; Canova CH; Klausner G; Dumas R; Rouger A; Pariente F; Lyothier A; Slama Y; Dol J; Perret J; Jenny C; Chea M; Pasdeloup F; Maingon P; Troussier I
    Cancer Radiother; 2019 Feb; 23(1):50-57. PubMed ID: 30558863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Audits of the quality management system and safety in radiotherapy: Lessons learned and future prospects].
    Leroy E; Marque A
    Cancer Radiother; 2016 Oct; 20(6-7):614-5. PubMed ID: 27614502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy quality and risk manager role optimization in 2017].
    Ponsard N; Brusadin G; Schick U
    Cancer Radiother; 2017 Oct; 21(6-7):670-672. PubMed ID: 28869197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N° 367-2019 Lignes Directrices Canadiennes Sur L'activité Physique Durant La Grossesse.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1538-1548. PubMed ID: 30343980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation TherapisTs Radiographer (RTTs) and risk management in radiotherapy: An international survey].
    Nait-Achour O; Cucchiaro S; Nardin S; Brusadin G
    Cancer Radiother; 2022 Oct; 26(6-7):846-850. PubMed ID: 35961930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AFQSR: A concrete and active implication in the service of the radiotherapy in 2018].
    Ponsard N
    Cancer Radiother; 2018 Oct; 22(6-7):537-539. PubMed ID: 30150088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The user, a stakeholder in the functioning of the hospital].
    Brun N
    Soins; 2015 Jun; (796):40-2. PubMed ID: 26146323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implementing new technology in radiation oncology: The French agency for nuclear safety (ASN) report].
    Lartigau ÉF; Lisbona A; Isambert A; Cadot P; Derreumaux S; Dupuis O; Gérard JP; Ledu D; Mahé MA; Marchesi V; Mazurier J; De Oliveira A; Phare O; Aubert B;
    Cancer Radiother; 2015 Oct; 19(6-7):616-20. PubMed ID: 26278991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic concepts and directions in the radiation therapy quality assurance processes of clinical trials.
    Thariat J; Loiseau C
    Cancer Radiother; 2023 Sep; 27(6-7):464-468. PubMed ID: 37541796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for patient with cardiac implantable electronic device, consensus from French radiation oncology society.
    Escande A; Frey P; Lacornerie T; Mervoyer E; Chargari C; Laurans M; Mornex F; Marijon É; Giraud P
    Cancer Radiother; 2022; 26(1-2):404-410. PubMed ID: 34969621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demography of radiation oncology residents in France in 2008: current situation and perspectives for the next three years].
    Dewas S; Pointreau Y; Rivera S; Blanchard P; Vautravers C; Marchand V; Mahe MA; Mazeron JJ; Kantor G
    Cancer Radiother; 2009 Jun; 13(3):153-60. PubMed ID: 19268618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for inspections of the French nuclear safety authority].
    Rousse C; Chauvet B;
    Cancer Radiother; 2015 Oct; 19(6-7):634-7. PubMed ID: 26321685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions et techniques de diagnostic prénatal visant l'obtention d'un prélèvement fœtal à des fins diagnostiques : Risques et avantages pour la mère et le fœtus.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S688-S703. PubMed ID: 28063574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interprofessional recommendations on behalf of Société française de radiothérapie oncologique for the prevention, protection and management of cyberattacks in radiation oncology].
    Giraud P; Fleury B; Le Prince C; Falk AT; Rousse C; Hance H; Santini JJ; Bicheron D; Palisson J; Hannoun-Lévi JM; Tack K; Marchesi V; Azria D
    Cancer Radiother; 2023 Dec; 27(8):683-688. PubMed ID: 37839920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.
    Fabiano E; Riou O; Pointreau Y; Périchon N; Durdux C
    Cancer Radiother; 2022; 26(1-2):315-322. PubMed ID: 34955411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.